The WIN 2012 Symposium, to be held in Paris, June 28-29, 2012, will be the next in the successful series of annual meetings dedicated to personalized cancer medicine. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside.
The main theme of the 2012 symposium will be Efficacy of biomarkers and personalized cancer therapeutics. This theme will be elaborated in various plenary sessions:
Organizer:
Congress by design
More information about WIN 2012 Symposium »
